Drug Survival in Atopic Dermatitis: Comparison of Biologics and <scp>JAK</scp> Inhibitors in the <scp>BioDay</scp> Registry

Lian F. van der Gang; Celeste M. Boesjes; Nicolaas P. A. Zuithoff; Inge Haeck; Octavian I. Bacoș‐Cosma; Laura Loman; Keneshka Atash; Veroniek E. M. Harbers; Simone Stadhouders; Albert J. Oosting; Anneke M. T. van Lynden‐van Nes; Klaziena Politiek; Antoni Gostyński; Wianda A. Christoffers; F.M. Garritsen; Annebeth Flinterman; Wouter R. H. Touwslager; Berit Velstra; Shiarra M. Stewart; Francine C. van Erp; Annemie F. S. Galimont‐Collen; Marie L. A. Schuttelaar; Marlies de Graaf; Marjolein de Bruin‐Weller

doi:10.1111/all.70187

Affiliated Institutions

Related Publications

Should myeloid and lymphoid neoplasms with <i><scp>PCM</scp>1‐<scp>JAK</scp>2</i> and other rearrangements of <i><scp>JAK</scp>2</i> be recognized as specific entities?

Barbara J. Bain , Shahzaib Ahmad

Summary Since the publication of the 2001 and 2008 World Health Organization classifications of tumours of haematopoietic and lymphoid tissues, there has been an increasing move...

2014 British Journal of Haematology 83 citations

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Daniel E. Johnson , Rachel A. O’Keefe , Jennifer R. Grandis

The IL-6/JAK/STAT3 pathway is aberrantly hyperactivated in many types of cancer, and such hyperactivation is generally associated with a poor clinical prognosis. In the tumour m...

2018 Nature Reviews Clinical Oncology 2871 citations

The JAK/STAT signaling pathway: from bench to clinic

Xiaoyi Hu , Jing Li , Maorong Fu +2 more

The Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway was discovered more than a quarter-century ago. As a fulcrum of many vital cellula...

2021 Signal Transduction and Targeted Therapy 2056 citations

Pathophysiology, Clinical Presentation, and Treatment of Psoriasis

April W. Armstrong , Charlotte Read

Importance Approximately 125 million people worldwide have psoriasis. Patients with psoriasis experience substantial morbidity and increased rates of inflammatory arthritis, car...

2020 JAMA 1915 citations

Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis

Wolfram Hoetzenecker , Rupert Ecker , Tamara Kopp +3 more

Apart from the long-used corticosteroids, topical calcineurin inhibitors (tacrolimus, pimecrolimus) represent novel therapeutic options for the treatment of atopic dermatitis. T...

2005 Journal of Allergy and Clinical Immun... 95 citations

Publication Info

Year: 2025
Type: article
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Drug Survival in Atopic Dermatitis: Comparison of Biologics and <scp>JAK</scp> Inhibitors in the <scp>BioDay</scp> Registry

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Lian F. van der Gang, 
                                
                                    Celeste M. Boesjes, 
                                
                                    Nicolaas P. A. Zuithoff
                                
                                et al.
                            
                            (2025). 
                            Drug Survival in Atopic Dermatitis: Comparison of Biologics and <scp>JAK</scp> Inhibitors in the <scp>BioDay</scp> Registry. 
                            Allergy
                            
                            .
                            https://doi.org/10.1111/all.70187

Identifiers

DOI: 10.1111/all.70187